Alwan A .2011 .. Global status report on noncommunicable diseases 2010 (ISBN: 978-92-4- 156422-9), 176 : .
American Heart Association. .2021 .Heart disease and stroke statistics-2021 at a glance. Retrieved from Amer Heart Assoc, 2(21) : 1-4.
American Heart Association. .2023 .Heart attack: Symptoms, causes and treatments. Amer Heart Assoc, 2(23) : 1-5.
Apple FS,Collinson PO,Kavsak PA .2017 .Highsensitivity cardiac troponin assays: A review of the current landscape. Clin. Chem, 55(8) : 1246-1255.
Bonanno FG .2022 .Management of hemorrhagic shock: physiology approach, timing and strategies. J Clin Med, 12(1) : 260.
Cohen AT,Kearon C .2014 .Management of blood clots: Anticoagulant therapy. N Engl J Med, 371(12) : 1095-1104.
Deb S,Wijeysundera HC,Ko DT,Tsubota H,Hill S,Fremes SE .2013 .Coronary artery bypass graft surgery vs percutaneous interventions in coronary revascularization: A systematic review. JAMA, 310(19) : 2086-2095.
Falk E .2006 .Pathogenesis of atherosclerosis. J Am Coll Cardiol., 47(8) : C7-C12.
Franklin BA,Cushman M .2011 .Recent advances in preventive cardiology and lifestyle medicine: A themed series. , 123(20) : 2274-2283.
Fuster V,Kelly BB,Lauer MS .2011 .Harrison's principles of internal medicine (18thed.). McGraw Hill Prof. , 18 : 2800.
Gersh BJ,White HD,Morrow DA .2016 .Management of acute myocardial infarction: The importance of early intervention. J. Amer. Coll, 67(12) : 1427-1444.
Govindarajan P,Ravichandran KS,Sundararajan S,Sreeja S S .2017 .Impact of modifiable and nonmodifiable risk factors on the prediction of stroke disease. In 2017 Int Conf Trends Elec Informat., : 985-989.
Grady KL,Cuffe MS .2019 .Current strategies for the management of coronary artery disease. J Amer Coll Cardiol, 73(2) : 221-234.
Griffo R,Ambrosetti M,Tramarin R,Fattirolli F,Temporelli PL,Vestri AR,Tavazzi L AR .2013 .Effective secondary prevention through cardiac rehabilitation after coronary revascularization and predictors of poor adherence to lifestyle modification and medication. Results of the ICAROS Survey. Int. J. Cardiol., 167(4) : 1390-1395.
Hirsch JA,Hoak JC .2001 .Management of deep vein thrombosis and pulmonary embolism. Circulation, 103(12) : 1831-1853.
Hussain S,Riaz M,Malik MA .2021 .Prevalence and risk factors of acute myocardial infarction in urban and rural Pakistan: A comparative study. J Pak Med, 71(3) : 789-795.
Jafar TH,Haaland BA,Rahman A,Razzak JA,Bilger M,Naghavi M,Hyder AA M .2020 .Non-communicable diseases and injuries in Pakistan: Strategic priorities. The Lancet, 395(10226) : 715-727.
Januzzi JL,Oster ME,Mehta SR .2018 .Troponin testing in acute coronary syndromes: A review. J Amer Coll. Cardiol., 71(19) : 2181-2192.
Khan MS,Jafary FH,Faruqui AM,Rasool SI,Hatcher J,Chaturvedi N,Jafar TH .2020 .High prevalence of modifiable cardiovascular risk factors among adults in Pakistan: A population-based survey. J Pub Health, 42(2) : 345-353.
Khera AV,Cuchel M,Devaney JM M .2016 .Association of increased genetic risk of coronary artery disease with atherosclerotic plaque burden and myocardial infarction. J Amer Coll Cardiol, 67(21) : 2488-2498.
Li S and Deb A .2024 .A humanized monoclonal antibody targeting an ectonucleotidaserescuescardiac metabolism and heart function after myocardial infarction. Cell Rep Med, 5(11) : 101795.
Libby P .2021 .The changing landscape of atherosclerosis. Nature, 592(7855) : 533-543.
Libby P,Ridker PM,Hansson GK .2019 .Inflammation in atherosclerosis: From pathophysiology to practice. J. Amer Coll Cardiol, 74(12) : 1587-1597.
Luscher TF,Dimmeler S TF .2018 .The role of endothelial dysfunction in myocardial infarction. Europ Heart J., 39(24) : 2290-2297.
Mehta LS,Beckie TM,DeVon HA,Grines CL,Krumholz HM,Johnson MN,Wenger NK .2020 .Acute myocardial Infarction in Women: A Scientific Statement. The Amer Heart Assoc, 141(9) : e1-e18.
Mehta RH,Pappas PA .2016 .Gender differences in myocardial infarction: Implications for care and outcomes. Amer Heart J, 174 : 1-8.
Mozaffarian D,Wilson PW,Kannel WB .2008 .Beyond established and novel risk factors: lifestyle risk factors for cardiovascular disease. Circulation, 117(23) : 3031-3038.
Porreca F and Ossipov MH .2009 .Nausea and vomiting side effects with opioid analgesics during treatment of chronic pain: Mechanisms, implications and management options. Pain Med, 10(4) : 654-662.
Roe MT,Becker RC .2017 .Current strategies for the management of myocardial infarction. Amer Heart J, 8(9) : 85-96.
Ross R .1999 .Atherosclerosis an inflammatory disease. N Engl J. Med, 340(2) : 115-126.
Sah AK .2025 .Prognostic biomarkers: Predicting disease outcomes. The Potential of Cancer Biomarkers. Elsevier, : 211-238.
Severs N J and Robenek H .2024 .Constituents of the arterial wall and atherosclerotic plaque: An introduction to atherosclerosis. , 45 : 50-49.
Steg PG,James SK,Atar D SK .2012 .ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Europ Heart J, 33(6) : 256-320.
Thygesen K,Jaffe JS,AS JS .2018 .Fourth universal definition of myocardial infarction. J Amer Coll. Cardiol., 72(18) : 2231-2264.
Vaccarino V,Cange K and O'Neil C .2018 .Sex differences in clinical outcomes following myocardial infarction. Circulation, 138(21) : 2264-2271.
Virani SS,Alonso A,Aparicio HJ,Benjamin EJ,Bittencourt MS,Callaway CW,Tsao CW .2021 .. Heart disease and stroke statistics- 2021 update: A report from The American Heart Association. Circulation, 143(8) : e254-e743.
Wang Y,Yang J,Zhang J .2016 .Myocardial infarction in women: Clinical features and outcomes. J Women's Health, 25(4) : 347-356.
World Health Organization .2021 .Cardiovascular diseases (CVDs). WHO Report, 2(4) : 1-5.
Yellon DM,Hausenblas H DM .2016 .Reperfusion therapy for myocardial infarction: Advances and controversies. J. Clin. Investn, 126(12) : 4237-4244.